Alkermes plc. (ALKS) income statement
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30208% above fair value
$45.45−1.08 (-2.32%)
Close on Nov 17, 2026Market cap $7.62BP/E 119.6Yield –
Alkermes plc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 84.6%
- Operating margin
- 7.0%
- Net margin
- 4.0%
- Return on equity, FY2025
- 14.7%
Financial strength
- Current ratio
- 2.30
- Debt to equity
- 0.83
- Debt to assets
- 34.2%
- Cash to current liabilities
- 77.3%
Valuation
- P/E ratio
- 119.6
- Price to sales
- 4.57
- Price to book
- 4.22
- Dividend yield
- –
See a number that looks wrong?